This rule was adopted to protect the health, safety, and
welfare of the public. This rule places newly identified compounds, including
their isomers, esters, ethers, salts and salts of isomers, esters, and ethers,
whenever the existence of these isomers, esters, ethers, or salts is possible
within the specific chemical designation under Schedule I of the Georgia
Controlled Substances Act, Section
16-13-25(1)as
follows:
(RR)
trans-3,4-dichloro-N-(2-(dimethylamino)cyclohexyl)-N-methylbenzamide
(U-47700)
(b) This rule is based on
the following findings of the Board:
(1) that
Synthetic Opiates have an extremely high potential for abuse;
(2) that scientific evidence and scientific
knowledge of the pharmacological effects of these compounds demonstrate that
the public is at extreme risk if they are not regulated as controlled
substances;
(3) that the pattern of
abuse of these compounds and the scope and significance of that abuse support
regulation;
(4) that there exists
an imminent peril to the public health and welfare with regard to the abuse of
these compounds;
(5) that these
compounds have the same risk to the public health of citizens of the State of
Georgia as other substances already contained in Schedule I under the
Controlled Substances Act; and
(6)
that these compounds have no known precursor already scheduled under the
Act.
Notes
Ga. Comp. R. & Regs.
R. 480-34-.10
O.C.G.A. ยงยง
16-13-22,
26-4-28,
50-13-4.
Original Rule
entitled "Synthetic Opiates" adopted as ER. 480-34-0.30-.10. F. and eff.
April 22, 2016, the date of
adoption.
Adopted: Permanent Rule of the same title. F.
June 22, 2016; eff.
July 12, 2016.
